Juan J. Rubio - Publications

Mesenchymal stromal cell therapy for COVID-19 acute respiratory distress syndrome: a double-blind randomised controlled trial.

Journal: Bone marrow transplantation

Published: July 14, 2023

Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.

Journal: Trials

Published: December 07, 2020

Kidney Transplants in Controlled Donation Following Circulatory Death, or Maastricht Type III Donors, With Abdominal Normothermic Regional Perfusion, Optimizing Functional Outcomes.

Journal: Transplantation direct

Published: November 25, 2020

Organ Donation and Transplantation During the COVID-19 Pandemic: A Summary of the Spanish Experience.

Journal: Transplantation

Published: November 09, 2020

COVID-19 in Spain: Transplantation in the midst of the pandemic.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: March 23, 2020

Donation after circulatory death and its expansion in Spain.

Journal: Current opinion in organ transplantation

Published: November 10, 2017

Validation of a new proposal to avoid donor resuscitation in controlled donation after circulatory death with normothermic regional perfusion.

Journal: Resuscitation

Published: March 05, 2017

Progressive increase in brain glucose metabolism after intrathecal administration of autologous mesenchymal stromal cells in patients with diffuse axonal injury.

Journal: Cytotherapy

Published: August 20, 2016